🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This trial is conducted in China. The aim of the trial is to evaluate the e...
Status
Recruiting
Location
Peking University People's Hospital
Start Date
2024-11-29
Trial ID
NCT06716216
This is a multicenter, randomized, double-blind, placebo-controlled phase I...
Status
Recruiting
Location
Peking University People's Hospital
Start Date
2024-10-28
Trial ID
NCT06704581
To assess the effect of BGM0504 injection versus placebo on weight loss in ...
Status
Completed
Location
The Third Xiangya Hospital of Central South University
Start Date
2023-10-13
Trial ID
NCT06973681
The purpose of the study is to evaluate the influence of BGM0504 injection ...
Status
Completed
Location
The First Affiliated Hospital of Yunnan University of Traditional Chinese Medicine (Yunnan Provincial Hospital of Traditional Chinese Medicine)
Start Date
2025-03-24
Trial ID
NCT06920056
Treatments Being Tested
This trial is conducted in Indonesia. The aim of the trial is to evaluate t...
Status
Recruiting
Location
RS Universitas Indonesia
Start Date
2025-07-04
Trial ID
NCT07064486
Treatments Being Tested
This is a multicenter, randomized, double-blind, placebo-controlled phase I...
Status
Recruiting
Location
Peking University People's Hospital
Start Date
2024-12-02
Trial ID
NCT06716203
To evaluate the efficacy and safety of BGM0504 compared with Tirzepatide in...
Status
Recruiting
Location
Peking University People's Hospital
Start Date
2025-04-03
Trial ID
NCT06911203
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of BGM0504...
Status
Completed
Location
The Third Xiangya Hospital of Central South University
Start Date
2023-08-30
Trial ID
NCT06974825
This is a Phase 1, double-blind, parallel-arm ,placebo-controlled study. Th...
Status
Completed
Location
Pharmaron CPC, Inc
Start Date
2024-10-21
Trial ID
NCT06714955